• Intravesical gemcitabine after surgery significantly reduces bladder cancer recurrence

    4 monthes ago - By Healio

    Edward M. Messing
    Flushing the bladder with gemcitabine rather than saline immediately after surgery significantly reduced the risk for recurrence of suspected low-grade nonmuscle-invasive urothelial cancer, according to study data published in JAMA.
    The practice is already widely used in Canada and throughout Europe.
    “The real importance of this study is that we now have a readily available drug that's fairly inexpensive, well-tolerated and effective,” Edward M. Messing, MD, professor of urology and professor of oncology and pathology at the University of Rochester School of
    Read more ...

     

  • STAG2 identified as biomarker for bladder cancer recurrence, progression

    4 monthes ago - By Healio

    Todd Waldman
    STAG2 mutations served as an independent predictor of progression and recurrence of papillary nonmuscle-invasive bladder cancer, according to results of a validation study.
    “Nonmuscle-invasive bladder cancer is extremely common and is extremely expensive to treat,” Todd Waldman, MD, PhD, professor of oncology at Georgetown Lombardi Comprehensive Cancer Center and director of the Georgetown MD/PhD Dual Degree Program, told HemOnc Today. “This new biomarker could help make it possible to better identify those patients who would and would not benefit from extensive
    Read more ...